Exopharm (ASX:EX1) Share Price and News

Market Cap (3-Jun) $27,342,400 (1,032nd)	Close (30-Jun) $0.008 0 (0%)	Volume (30-Jun) 285,280	Shortsold (12-Dec) 6,497 (0.00%) (681st)
52w High $0.000	52w Low $0.000	P/E -	EPS -0.09

	Subject
	EX1 EX1 Ann: Initial Director's Interest Notice - MD
	1 (current) 2 3
	EX1 EX1 Ann: Change of Director's Interest Notice - CB
	EX1 EX1 Ann: Final Director's Interest Notice - JW
	EX1 EX1 Ann: Update & Changes to the Board
	EX1 EX1 Ann: Change in substantial holding - ID
	EX1 EX1 Ann: Application for quotation of securities - EX1
	EX1 EX1 Ann: Application for quotation of securities - EX1
	EX1 EX1 Ann: Notification regarding unquoted securities - EX1
	EX1 EX1 Ann: Update - Proposed issue of securities - EX1
	EX1 EX1 Ann: Change in substantial holding - ID
	EX1 EX1 Ann: Change of Director's Interest Notice - JW
	EX1 EX1 Ann: Results of Meeting
	EX1 EX1 Ann: Application for quotation of securities - EX1
	EX1 EX1 Ann: EX1 early stage success with in house Elastin (ELN) program
	EX1 EX1 Ann: Quarterly Activities Report and Appendix 4C
	EX1 EX1 Ann: Results of Non-Renounceable Rights Issue
	EX1 EX1 Ann: Update - Proposed issue of securities - EX1
	EX1 EX1 Ann: Rights Issue Prospectus and Extension of Closing Date
	EX1 EX1 Ann: Despatch of Non-Renounceable ProRata Rights Issue Prospectus
	EX1 EX1 Ann: Notice of General Meeting/Proxy Form
	EX1 EX1 Ann: Proposed issue of securities - EX1
	EX1 EX1 Ann: Proposed issue of securities - EX1
	EX1 EX1 Ann: Exopharm Limited announces Non-Renounceable Pro Rata Rights
	EX1 EX1 Ann: Notice to Ineligible Shareholder
	EX1 EX1 Ann: Disclosure Document - Rights Issue Prospectus
	EX1 EX1 Ann: Notification regarding unquoted securities - EX1
	EX1 EX1 Ann: Notice under s708A(12C)(e) of the Corporations Act 2001(Cth)
	EX1 EX1 Ann: EX1 to Receive $1m from the Issue of Convertible Notes
	EX1 EX1 Ann: Trading Halt
	EX1 EX1 Ann: EX1 to Receive $0.431m in Prepayment of R&D Tax Incentive
	EX1 EX1 Ann: Appendix 4D and Half Year Report for period 31 December 2022
	EX1 EX1 Ann: Initial Director's Interest Notice - CB
	EX1 EX1 Ann: Final Director's Interest Notice - JK
	EX1 EX1 Ann: Board changes adds Australian capital markets expertise
	EX1 EX1 Ann: Ceasing to be a substantial holder
	EX1 EX1 Ann: Added Funding for 2023
	EX1 EX1 Ann: Trading Halt
	EX1 EX1 Ann: Quarterly Activities Report and Appendix 4C
	EX1 EX1 Ann: Notification of cessation of securities - EX1
	EX1 EX1 Ann: Final Director's Interest Notice
	EX1 EX1 Ann: Operations review, Board and other changes
	EX1 EX1 Ann: EX1 to Receive $0.96m in Prepayment of R&D Tax Incentive
	EX1 EX1 Ann: Constitution
	EX1 EX1 Ann: Results of Meeting
	EX1 EX1 Ann: Exosome manufacture taken to the next level
	EX1 EX1 Ann: EX1 will commence LEAP technology transfer to AIRM under MSA
	EX1 EX1 Ann: Upcoming Conference Presentation ANZSEV2022
	EX1 EX1 Ann: Quarterly Activities Report and Appendix 4C
	EX1 EX1 Ann: Upcoming Webinar
	EX1 EX1 Ann: Exopharm Received R&D Tax Incentive Refund

Similar Companies

CSL

Clinuvel Pharmaceuticals

CUV

Immutep

IMM

Imugene

IMU

Mesoblast

MSB

Opthea

OPT

Paradigm Biopharmaceuticals

PAR

PYC Therapeutics

PYC

Race Oncology

RAC

Telix Pharmaceuticals

TLX

End of Day Prices

Date	Close	Volume	Change
31-May	$0.02	3,375,302	0.00 (16.36%)
10-May	$0.03	0	0.00 (0.00%)
09-May	$0.03	0	0.00 (0.00%)
08-May	$0.03	0	0.00 (0.00%)
07-May	$0.03	0	0.00 (0.00%)
06-May	$0.03	0	0.00 (0.00%)
03-May	$0.03	0	0.00 (0.00%)
02-May	$0.03	0	0.00 (0.00%)
01-May	$0.03	0	0.00 (0.00%)
30-Apr	$0.03	0	0.00 (0.00%)
29-Apr	$0.03	0	0.00 (0.00%)
26-Apr	$0.03	0	0.00 (0.00%)
24-Apr	$0.03	0	0.00 (0.00%)
23-Apr	$0.03	0	0.00 (0.00%)
22-Apr	$0.03	0	0.00 (0.00%)
0 up, 1 down, and 14 flat days

High $0.01	Low $0.01	Trades 7	Turnover $2,282	Volume 285,280
30 June 2023 at 3:59pm

High $0.01	Low $0.01	Trades 7	Turnover $2,282	Volume 285,280
30 June 2023 at 3:59pm

Exopharm Health Care

$0.008 (0%)

$0.008 (0%)

Followers

Prices

Announcements

Similar Companies

End of Day Prices